foxo4-dri senolytic peptide human trial Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Frontiers | FOXO4-DRI regulates endothelial

Can New Delivery Technologies Make Oral Peptides Perform Like Injectable Ones

A regulated infusion from one company and a research only vial sold with dosing instructions are different worlds

If you added too much water, you can still use the peptide

5-Amino-1MQ is a small-molecule inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme overexpressed in obese fat tissue that depletes NAD+ precursors and SAM

Bottom line: Dihexa is one of the most potent neurotrophic peptides ever developed, but this same power also makes it potentially dangerous

Our experienced practitioners stay abreast of the latest research and adhere to the highest safety standards when recommending off-label peptide therapies